TY  - JOUR

T1  - Selectively inhibiting malignant melanoma migration and invasion in an engineered skin model using actin-targeting dinuclear Ru-II-complexes

JO  - RSC Medicinal Chemistry

PY  - 2022/11/01

AU  - Raza A

AU  - Archer SA

AU  - Thomas JA

AU  - MacNeil S

AU  - Haycock JW

ED  - 

DO  - DOI: 10.1039/d2md00280a

PB  - Royal Society of Chemistry

Y2  - 2024/09/20

ER  -